This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

IPC The Hospitalist Company Graduates First Class Of Fellows In Hospitalist Leadership At UCSF

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice company, announced today that thirty-seven of its Practice Group Leaders from around the country have successfully completed the Fellowship in Hospitalist Leadership given by the University of California, San Francisco (UCSF) Division of Hospital Medicine and its Center for the Health Professions. Graduates of this Fellowship program have completed an intensive one-year training and education program designed to provide leadership skills to the hospitals they serve, with the goal of improving the quality of care and the efficiencies of the inpatient care delivery system.

The members of the first graduating class, selected from among the Company’s nearly 200 Practice Group Leaders, participated in a variety of learning modalities, including core program seminars, executive coaching sessions, webinars and on-site meetings. In addition to learning leadership skills, the Fellows also received training in quality improvement and patient safety. An important feature of the program is the mentored implementation project, where the Fellows selected a key area in their own hospital, and, working with UCSF program faculty, developed and executed a plan to improve it, with measurable results.

Adam Singer, M.D., chairman and CEO of IPC The Hospitalist Company, commented, “Our nation calls out for leadership from every corner of the political and economic arena, and this is especially true for our healthcare system. With the UCSF Fellowship program, IPC is demonstrating a commitment to provide the clinical leadership so urgently needed to hospitals and post-acute care facilities. Forging a true partnership with healthcare facilities by providing more expert physician leadership is, in our view, the surest path to true healthcare reform.”

Robert Wachter, M.D., who coined the term ‘hospitalist’ in the New England Journal of Medicine in 1996 and is the Chief of UCSF’s Division of Hospital Medicine, added, “As I discussed in my blog this week, the IPC Fellowship program is both transformative and groundbreaking, and points the way toward the future of hospital medicine. We must find ways to improve the quality, safety, and efficiency of hospital medicine. This Fellowship creates a cohort of physician-leaders who are trained and certified to do just that. My colleagues and I salute the new IPC Fellows who worked so hard to earn this achievement, and we look forward to tracking their progress.” Wachter serves as senior faculty for the Fellowship program, along with Ed O’Neil, director of the UCSF Center for the Health Professions and an internationally respected figure in healthcare leadership training. The co-directors of the fellowship are UCSF hospitalists and leadership experts Arpana Vidyarthi, M.D. and Niraj Sehgal, M.D., MPH.

A second cohort of more than forty IPC Practice Group Leaders has already started their UCSF Fellowship program. Anticipated graduation for this class is November 2012, at which time there will be approximately 80 Fellows in Hospitalist Leadership in the IPC practice groups.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,071.22 -41.93 -0.24%
S&P 500 1,977.80 -5.05 -0.25%
NASDAQ 4,505.8520 -6.3420 -0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs